AbbVie drops drug secrecy case against EU agency

LONDON (Reuters) - AbbVie, one of the two U.S. firms bringing an injunction against Europe's drugs regulator over the issue of trial data secrecy, said on Thursday it had withdrawn its lawsuit.

AbbVie, a pharmaceutical company, had sought an injunction in March last year to block Europe's medicines regulator from releasing "confidential" and "commercially-sensitive" information on its blockbuster rheumatoid arthritis drug.